Stock Offerings
Secondary · ATM · Shelf · PIPE Guide↗
858 results
858
Total Filings
$6907.5B
Total Raised
65
424B4 Offerings
248
ATM Programs
106
PIPEs
| Date ▼ | Ticker | Sector | Industry | Mkt Cap | Type | Offer Price | Price | vs Offer | Shares | Proceeds | Underwriters | Summary |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 7 | TPET | Energy | Oil & Gas Exploration & Production | $3M | ATM | — | $0.30 | — | — | — | — | Trio Petroleum Corp is selling up to $893,000 of common stock through an at-the-market offering via Ladenburg Thalmann, with proceeds for general corporate purposes. |
| Apr 6 | ONCY | Healthcare | Biotechnology | $84M | ATM | — | $0.84 | — | — | — | Jefferies | Oncolytics Biotech (ONCY) is conducting an at-the-market offering of up to $75 million in common stock through Jefferies, with proceeds for general corporate purposes. |
| Apr 6 | TPET | Energy | Oil & Gas Exploration & Production | $3M | ATM | — | $0.30 | — | — | — | — | Trio Petroleum Corp (TPET) is selling up to $945,000 of common stock through an at-market agreement with Ladenburg Thalmann, having already sold $20,027,510 under the program. |
| Apr 3 | NKTX | Healthcare | Biotechnology | $249M | ATM | — | $3.48 | — | — | — | Stifel | Nkarta Inc. is offering up to $100 million in common stock through an at-the-market offering via Stifel, with proceeds for general corporate purposes. |
| Apr 3 | INM | Healthcare | Biotechnology | $3M | ATM | — | $1.65 | — | — | — | — | InMed Pharmaceuticals Inc. is selling up to $1,213,648 of common shares at market prices through H.C. Wainwright & Co. via an at-the-market offering; proceeds will be used for general corporate purposes. |
| Apr 3 | NSPR | Healthcare | Medical - Devices | $33M | Public Offering |
$1.59
floor
|
$0.71 | -55.4% | — | — | — | Nanospectra Biosciences (NSPR) is selling up to $75 million in common stock at-the-market through BTIG as sales agent, with proceeds for general corporate purposes. |
| Apr 3 | AARD | Healthcare | Biotechnology | $115M | Public Offering |
$4.07
floor
|
$5.27 | +29.5% | — | — | Piper Sandler | Aardvark Therapeutics offering up to $150 million in common stock at-the-market through Piper Sandler; proceeds for general corporate purposes. |
| Apr 3 | RPGL | Technology | Software - Services | $2M | Public Offering |
$0.25
floor
|
$1.80 | +621.6% | — | — | — | Republic Power Group Limited is selling 40 million Class A ordinary shares at $0.25 per share for $10 million gross proceeds in a best-efforts offering; use of proceeds not specified. |
| Apr 2 | JEF | Financial Services | Financial - Capital Markets | $10.9B | Public Offering | — | $53.50 | — | — | — | Jefferies, Wells Fargo | Jefferies Financial Group Inc. is issuing auto-callable equity index linked securities due March 28, 2030, with 10% contingent quarterly coupons, potential principal loss, and automatic call features based on S&P 500, Russell 2000, and Dow Jones performance. |
| Apr 2 | SVC | Real Estate | REIT - Hotel & Motel | $286M | Public Offering |
$1.36
floor
|
$8.61 | +533.1% | — | — | B. Riley, Oppenheimer | Service Properties Trust (SVC) is selling 416.7 million common shares at $1.20 per share to raise approximately $500 million, with net proceeds of $472.5 million after underwriting discounts for general corporate purposes. |
| Apr 2 | HOTH | Healthcare | Biotechnology | $12M | Public Offering |
$0.70
floor
|
$0.88 | +25.9% | 2.9M | $2M | — | HOTH sells 2,857,144 common shares at $0.70/share to institutional investors, raising approximately $2.0 million in gross proceeds. |
| Apr 2 | ADAG | Healthcare | Biotechnology | $153M | Public Offering | — | $4.06 | — | — | — | — | Adagene Inc. is selling 18,666,000 ADSs (representing 23.3 million ordinary shares) at $4.61 per ADS to raise approximately $86 million; proceeds will be used for general corporate purposes. |
| Apr 2 | CLDX | Healthcare | Biotechnology | $2.6B | Public Offering |
$31.26
floor
|
$38.64 | +23.6% | 10.3M | $323M | Cowen | Celldex Therapeutics (CLDX) is offering 10,345,000 common shares at $29.00 per share, raising $300 million gross proceeds for general corporate purposes. |
| Apr 2 | OSTX | Healthcare | Biotechnology | $67M | Public Offering |
$1.71
floor
|
$1.50 | -12.3% | 2.5M | $4M | — | OS Therapies is raising approximately $3.5 million selling 2.5 million common shares at $1.40 each plus accompanying warrants, with proceeds for general corporate purposes. |
| Apr 2 | TANH | Consumer Defensive | Household & Personal Products | $3M | Public Offering |
$0.30
floor
|
$0.43 | +43.0% | — | — | — | Tantech Holdings Ltd is selling 7,166,671 Class A Common Shares at $0.30 per share in a registered direct offering to institutional investors, expected to raise approximately $2.15 million gross proceeds including concurrent warrant sales. |
| Apr 2 | INO | Healthcare | Biotechnology | $62M | Public Offering | — | $1.15 | — | — | — | Piper Sandler | # INO Offering Summary Inovio Pharmaceuticals is selling common stock with Series A and Series B warrants; specific share counts and pricing are redacted in this preliminary 424B5 filing dated April 1, 2026. |
| Apr 2 | INO | Healthcare | Biotechnology | $62M | Public Offering | — | $1.15 | — | 12.5M | — | Piper Sandler | Inovio Pharmaceuticals is selling 12.5 million common shares with Series A and B warrants at $1.40 per unit, raising $17.5 million for general corporate purposes. |
| Apr 2 | KYTX | Healthcare | Biotechnology | $399M | ATM |
$7.87
floor
|
$9.11 | +15.8% | — | — | Jefferies | Kyverna Therapeutics selling up to $100 million common stock at-the-market through Jefferies at $7.87/share; proceeds for general corporate purposes. |
| Apr 2 | CTNT | Consumer Cyclical | Auto - Dealerships | $25,371 | ATM |
$2.09
floor
|
$1.55 | -25.6% | — | — | — | Cheetah Net Supply Chain Service Inc. selling up to $70 million of Class A common stock at market prices through AC Sunshine Securities as sales agent; proceeds for general corporate purposes. |
| Apr 2 | CDTTW | — | — | — | ATM |
$5.10
floor
|
— | — | — | — | — | CDT increased its at-the-market offering from $3.6 million to $76.1 million in common stock at $5.10/share via A.G.P., with proceeds for general corporate purposes. |
Data sourced from SEC EDGAR 424B4, 424B5, and 8-K filings. IPOs hidden by default.
Learn more →